Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By boosting these https://alvingito407825.estate-blog.com/35219716/tirzepatide-a-promising-new-treatment-for-obesity